Each week, we highlight recent news, stories, and updates from across the Cortado Ventures portfolio. From product advancements to industry recognition, these updates reflect the continued growth and impact our companies are driving across critical industries.
Subscribe to the Doubleshot Newsletter for more updates. Follow us on LinkedIn, Medium, and Instagram to stay connected.
This Week In the Portfolio – 05/25-05/29
CorriXR Therapeutics – 05/28
CorriXR Therapeutics was featured in Precision Medicine Online for its work developing an inhaled gene therapy designed to treat lung cancer directly in the lungs. The company’s approach targets NRF2, a key driver of treatment resistance in squamous cell lung tumors, with the goal of restoring the effectiveness of standard-of-care therapies.
Read more here.
Myri Health – 05/28
Myri Health continues to gain international recognition for its leadership in maternal health innovation. The company was selected for the QSTP × Merck FemTech Accelerator, a highly competitive global program supporting advancements in women’s health, maternal care, digital health, and reproductive health, after being chosen from hundreds of applicants across 47 countries. In addition, Founder & CEO Dr. Pinkey Patel was shortlisted for Organon META’s Women’s Health Accelerator in recognition of her work building an AI-enabled maternal health platform that supports women throughout pregnancy and postpartum.
Read more about these wins here and here.
**
Cortado Ventures is an early-stage venture capital firm that invests in ambitious, growth-driven companies, backing a new generation of economic prosperity for the Midcontinent region, defined as Oklahoma, Texas, Arkansas, Missouri, Colorado, Kansas and New Mexico. As one of the largest VC funds in Oklahoma, Cortado’s focus is on tech companies bringing innovative solutions to the frontier, space, energy and logistics, life sciences, and the future of work sectors.
For more information, visit cortado.ventures.
Support MidconVC by clicking HERE.